“…In 13 studies, the antimicrobial susceptibility was defined according to the Clinical and Laboratory Standards Institute guidelines (11,12,16,17,20,22,23,(27)(28)(29)(30)(31)(32), while in 10 other studies the guidelines of the Comité de l' Antibiogramme de la Société Française de Microbiologie were used (13-15, 24-26, 33-36). The susceptibility breakpoints that were used were not provided in 5 studies (18,19,21,37,38). Seventeen of the included studies had a prospective nature (12, 16-19, 21-23, 26, 27, 29-32, 35, 37, 38), while 11 had a retrospective nature (11, 13-15, 20, 25, 28, 33, 34, 36).…”